Table 4.
ROC curve analysis of CRSS regarding long-term clinical outcomes.
| AUC | P-Value | Optimal Cutoff | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|
| All-cause death | 0.614 | <0.001 | 9.8 | 55.5 | 67.7 |
| Cardiac death | 0.633 | <0.001 | 9.8 | 61.2 | 67.6 |
| Myocardial infarction | 0.620 | <0.001 | 11.2 | 48.7 | 71.8 |
| Unplanned revascularization | 0.588 | <0.001 | 5.6 | 64.8 | 50.6 |
| Stroke | 0.609 | <0.001 | 12.4 | 43.5 | 75.5 |
| MACCE | 0.609 | <0.001 | 9.7 | 49.9 | 69.0 |
ROC, receiver operating characteristic; CRSS, clinical residual SYNTAX score; AUC, area under the curve; and MACCE, major adverse cardiovascular and cerebrovascular events.